SANGAMO THERAPEUTICS, INC. Foreign Currency Transaction Gain (Loss), before Tax
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Foreign Currency Transaction Gain (Loss), before Tax of $700.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-05-14
- SANGAMO THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $700.00K.
- SANGAMO THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$100.00K.
- SANGAMO THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was -$2.40M, a 1300.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$3.70M, a 331.25% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was $1.60M.
- SANGAMO THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2018 was -$602.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $700.00K 10-Q · filed 2026-05-14 | $700.00K derived: sum of 2 quarters · filed 2026-05-14 | $600.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.80M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$100.00K derived: sum of 2 quarters · filed 2026-03-30 | -$2.50M derived: sum of 3 quarters · filed 2026-03-30 | -$3.70M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$100.00K 10-Q · filed 2025-11-06 | -$2.50M derived: sum of 2 quarters · filed 2025-11-06 | -$3.70M 10-Q · filed 2025-11-06 | -$1.80M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.60M 10-Q · filed 2025-08-07 | -$1.70M derived: sum of 3 quarters · filed 2026-05-14 | -$2.60M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | -$1.20M 10-Q · filed 2026-05-14 | $700.00K derived: sum of 2 quarters · filed 2026-05-14 | -$200.00K derived: sum of 3 quarters · filed 2026-05-14 | $0.00 derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.00M derived: sum of 2 quarters · filed 2026-03-30 | $1.20M derived: sum of 3 quarters · filed 2026-03-30 | $1.60M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$900.00K 10-Q · filed 2025-11-06 | -$700.00K derived: sum of 2 quarters · filed 2025-11-06 | -$300.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $600.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-12 | |||
| 2018-12-31 | -$602.00K 10-K · filed 2019-03-01 |